Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06358040 · ClinicalTrials.gov registry record · NA

Opioid Dispenser for Microdiscectomy/Laminectomy

A NA study of Pain, Postoperative and Opioid Use, sponsored by Hospital for Special Surgery, New York.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06358040 is a NA study of Pain, Postoperative and Opioid Use that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 30 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06358040, a NA study of Pain, Postoperative and Opioid Use, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The opioid crisis continues to plague the United States. While great strides have been made nationwide to decrease overprescribing, improvements are still needed to appropriately educate patients on the safe and responsible use, storage and disposal of opioids. Pain after surgery is often treated with opioid medications. Opioid medications can have side effects. Some side effects are relatively minor (constipation, nausea, vomiting), while others are more severe (sedation, abnormal breathing, etc.) and can lead to serious illness or death. Opioid pain medications when used the wrong way may also be addictive. Due to theses side effects, sometimes patients feel uncomfortable about taking these medications, and doctors prescribe them very cautiously. However, when used properly and safely, opioid pain medications are excellent pain relievers. Addinex, a technology company, has developed a device to help patients take opioids more safely. In this study the investigators aim to enroll a total of 30 patients who undergo spine surgery. Half will be randomly assigned to receive a standard pill bottle with opioids at discharge and will download a mobile app so that they can record their daily pain scores and the number of opioids they take for two weeks after surgery. The other half will receive the new opioid dispenser filled with opioids and a mobile app that generates a passcode that opens that device only at designated times. For this group of patients, every time the patient wants to take an opioid, they need to go to the app, enter their pain score before the app generates a passcode. The investigators will be tracking all study patients' opioid use and pain scores for the two weeks after surgery, will count how many pills they have left over 14 days after their surgery during a live telehealth session, and ask patients how they liked using the device. Results from this study will help understand if the Addinex device could potentially be useful to patients in the fu

Interventions

  • DEVICE Opioid-Dispensing Device
  • OTHER App
  • OTHER Standard Opioid Pill Bottle

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-10
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT06358040

The ClinicalTrials.gov registry entry for NCT06358040 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (89% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 3 interventions - of which Opioid-Dispensing Device is the first listed.

NCT06358040 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06358040 about?

NCT06358040 is a clinical study titled "Opioid Dispenser for Microdiscectomy/Laminectomy". The opioid crisis continues to plague the United States. While great strides have been made nationwide to decrease overprescribing, improvements are still needed to appropriately educate patients on the safe and responsible use, storage and disposal of opioids. Pain after surgery is often treated wi...

What is the current status of trial NCT06358040?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-10. Estimated completion is 2026-12.

What conditions does trial NCT06358040 study?

This clinical trial studies the following conditions: Pain, Postoperative, Opioid Use, Medical Device, Diskectomy, Laminectomy.

What interventions are being tested in trial NCT06358040?

The interventions under investigation include: Opioid-Dispensing Device (DEVICE), App (OTHER), Standard Opioid Pill Bottle (OTHER).

Who is sponsoring clinical trial NCT06358040?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06358040 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.